is a health tech startup company that envisions transforming ultrasound into the stethoscope of the 21st century. MEDO builds cutting edge artificial intelligence that pairs with ultrasound devices to facilitate novice users’ ability to detect common and critical conditions.

MEDO’s cloud-based ultrasound platform, which is FDA-cleared, is capable of segmenting anatomical structures from ultrasound images and cine clips, visualizing them in 3D and translating them into relevant clinical information in a couple of seconds.